2.23 USD
↗ 1.16 (108.41%)AT CLOSE (11:59 AM EDT)
Propanc Biopharma, Inc. Common Stock
PPCBNASDAQ • USD
1.95
↘ 0.28 (12.78%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
1.95
↘ 0.28 (12.78%)
Market: CLOSED
PPCB is currently priced at $2.20. The technical outlook is "Buy" based on moving average alignment, RSI, and MACD signals. Notable factors include negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Aug 27, 2026.
Open?$3.51
High?$4.13
Low?$1.98
Prev. Close?$1.07
Volume?97.3M
Avg. Volume?126.6K
VWAP?$3.22
Rel. Volume?768.60x
Bid / Ask
Bid?$2.21 × 100
Ask?$2.25 × 100
Spread?$0.04
Midpoint?$2.23
Valuation & Ratios
Market Cap?2.4M
Shares Out?3.5M
Float?1.6M
Float %?71.5%
P/E Ratio?N/A
P/B Ratio?0.25
EPS?-$8.47
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
Themes
Address
302/6 BUTLER STREET
CAMBERWELL, VICTORIA, C3 3124
Phone: 61-03-9882-0780
CAMBERWELL, VICTORIA, C3 3124
Phone: 61-03-9882-0780
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?3.45%Low
Short Interest?56.3K
Days to Cover?1.0
Free Float1.6M
Avg Daily Volume235.8K
Settlement Date2026-08-14
Financial Health
Current Ratio?2.37Strong
Quick Ratio?2.37Strong
Cash Ratio?0.13Low
Debt/Equity?0.07Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.25CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.1CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-196.3%WEAK▾
S&P3
ROA?-134.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-4112751
Enterprise Value?$2.6M
Fundamentals ratios updated end of day